Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alteplase in MRI-Selected Unwitnessed Acute Ischemic Stroke
NCT01282242Phase 2Completed
- Start
- Jan 2011
- Primary completion
- Jan 2016
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of tissue-plasminogen activator in ischemic stroke. Started Jan 2011; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01282242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01282242.